Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-21-052277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-18 | 2021-08-16 | QNCX | LOWE CHRISTOPHER P. | COO, CFO | S - Sale+OE | $95.31 | -22.0K | 33.2K | -40% | -$2.10M |
| DM | 2021-08-18 | 2021-08-16+ | QNCX | LOWE CHRISTOPHER P. | COO, CFO | M - OptEx | $2.23 | +52.0K | 52.0K | New | +$116.0K |
| DM | 2021-08-18 | 2021-08-16+ | QNCX | LOWE CHRISTOPHER P. | COO, CFO | M - OptEx | $0.00 | -52.0K | 133.3K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 1,100 | $97.28 | 32,077 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2021-08-16 | S | D | 2,077 | $98.90 | 30,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-17 | M | A | 30,000 | $2.23 | 60,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-16 | S | D | 7,335 | $95.02 | 35,507 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2021-08-16 | S | D | 9,158 | $94.23 | 42,842 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2021-08-16 | M | A | 22,000 | $2.23 | 52,000 | D | — | — | |
| 7 | Common | Common Stock | 2021-08-16 | S | D | 2,330 | $96.32 | 33,177 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 8 | Derivative | Stock Option (right to buy) | 2021-08-16 | M | D | 22,000 | $0.00 | 163,294 | D | $2.23 · — to 2028-11-27 | 22,000 Common Stock | (F6) The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022. |
| 9 | Derivative | Stock Option (right to buy) | 2021-08-17 | M | D | 30,000 | $0.00 | 133,294 | D | $2.23 · — to 2028-11-27 | 30,000 Common Stock | (F6) The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022. |